LumiraDx Receives CE Mark for Two Multiplex Tests: LumiraDx

LONDON, June 8, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX) today announced that it has achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2

Related Keywords

United Kingdom , London , City Of , Sanjay Malkani , Exchange Commission , Fast Lab Solutions , Lumiradx Fast Lab Solutions , Prnewswire Lumiradx Limited Nasdaq , Lumiradx Fast Lab , Lumiradx Platform , Securities Litigation Reform Act , Annual Report , Lumiradx , Eceives , Park , Multiplex , Tests , Ual , Target , Cars , Star , Omplete ,